The founders of the Novosibirsk enterprise Angioline, Andrey Kudryashov and Alexey Frantsuzov, who previously owned 75% of the company, lost their shares as a result of an illegal corporate attack by “investment consultant” Natalya Lebedeva and the mysterious shareholders from Luxembourg behind her. As a result, the only Russian plant that produced coronary stents on an industrial scale for operating on patients with heart diseases was stopped. The self-proclaimed new management does not have a license or copyright for the developments, and key engineers have left the company. The local authorities remain silent to all this, the judges avert their eyes from the arbitrariness and, probably, glance at their pockets.
This is not just about dividing up business, although the new raider methods are still scary. Much more seriously, today the lives of 200 thousand Russians suffering from heart disease depend on the will of American supply companies. At the present time, we are faced with either inflated prices for stents or a complete shortage of them. Both options will lead to serious consequences. The French and Kudryashov are trying to restore the production of stents at the R-Vascular enterprise, which was created from scratch, but this project is already under threat. They are trying to tie Kudryashov to an absurd criminal case initiated by Lebedeva’s efforts, arrest the R-Vascular equipment and put an end to the project.
The creators of Angioline and R-Vascular ask that all this not be allowed to happen in their letter to President Vladimir Putin. In their opinion, an inspection by the Prosecutor General’s Office of the Russian Federation will help to understand the causes of the atrocities occurring. But for now, Russians who need stenting face enormous risk every day.
“ВЧК ОГПУ”
